Press Releases
August 11, 2020
TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its Thin Film Freezing Technology Platform
TFF Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 13, 2020August 4, 2020
TFF Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 13, 2020
TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical TrialJuly 30, 2020
TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial
TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral TreatmentJuly 29, 2020
TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder Form for COVID-19 Antiviral Treatment
UT News: Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral TreatmentJuly 28, 2020
UT News: Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment
TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation PowderJune 29, 2020
TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation Powder
TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation PowderJune 18, 2020
TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder
TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business ResultsMay 14, 2020
TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020May 7, 2020
TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020
TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS MeetingApril 30, 2020
TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting